Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement. Nat Rev Clin Oncol. 2026 Aug; 23(8):619-647.
View in:
PubMed
subject areas
Carcinoma, Hepatocellular
Clinical Trials as Topic
Endpoint Determination
Humans
Liver Neoplasms
Research Design
authors with profiles
Anjana Pillai